Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viral Recombination00:57

Viral Recombination

25.2K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
25.2K
Viral Structure00:56

Viral Structure

74.6K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
74.6K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

302
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
302
Viral Mutations00:36

Viral Mutations

39.9K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.9K
Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

794
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
794
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

1.6K
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characteristics of Young Children Hospitalized With Acute Respiratory Failure From Infection With Respiratory Syncytial Virus, SARS-CoV-2, or Both, November 2023-March 2024.

Open forum infectious diseases·2026
Same author

Heterozygous variants in DOCK2 leading to susceptibility to viral illnesses.

The Journal of allergy and clinical immunology·2026
Same author

COVID-19 pandemic and enrollment of critically Ill children in randomized clinical trials.

Frontiers in pediatrics·2025
Same author

Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants - 24 States, December 2024-April 2025.

MMWR. Morbidity and mortality weekly report·2025
Same author

Star of the Diabetic Macular Show: Stellate Nonhereditary Idiopathic Foveomacular Retinoschisis (SNIFR).

Journal of ophthalmic & vision research·2025
Same author

Resolvin D1-mediated cellular crosstalk protects against MASH.

JHEP reports : innovation in hepatology·2025

Related Experiment Video

Updated: Feb 4, 2026

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
07:34

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies

Published on: April 11, 2012

20.1K

Viral Sepsis in Children.

Neha Gupta1, Robert Richter1, Stephen Robert2

  • 1Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, United States.

Frontiers in Pediatrics
|October 4, 2018
PubMed
Summary

Viral sepsis in children is often overlooked, despite viruses being potential causes of culture-negative sepsis. Understanding viral sepsis is crucial for appropriate treatment and infection control.

Keywords:
childrenpediatricsecondary bacterial infectionssepsisviral coinfectionsviral infectionsviral sepsis

More Related Videos

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis
04:01

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis

Published on: June 14, 2024

1.5K
A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

546

Related Experiment Videos

Last Updated: Feb 4, 2026

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
07:34

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies

Published on: April 11, 2012

20.1K
Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis
04:01

Author Spotlight: Advanced Integrated Model for Sepsis-Induced Myopathy and Single-Cell Metabolic Analysis

Published on: June 14, 2024

1.5K
A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

546

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Virology

Background:

  • Sepsis in children is often presumed bacterial, but cultures are frequently negative.
  • Viral pathogens are underrecognized causes of culture-negative sepsis globally.
  • The epidemiology, burden, and mortality of viral sepsis in children require further elucidation.

Purpose of the Study:

  • To review the current understanding of viral sepsis in children.
  • To address the epidemiology and pathophysiology of viral sepsis.
  • To outline clinical manifestations, diagnostics, and management specific to viral sepsis.

Main Methods:

  • Literature review of viral sepsis in pediatric populations.
  • Analysis of epidemiological data, pathophysiology, and host-pathogen interactions.
  • Synthesis of information on clinical presentation, diagnostic approaches, and therapeutic strategies.

Main Results:

  • Viral sepsis is a significant, yet poorly understood, contributor to pediatric sepsis.
  • Recognition of viral etiology impacts antibiotic use, infection control, and antiviral therapy.
  • Specific diagnostic and management considerations exist for viral sepsis.

Conclusions:

  • Viral sepsis in children is an important clinical entity that warrants greater attention.
  • Accurate diagnosis and timely management of viral sepsis can improve outcomes.
  • Further research is needed to fully characterize the impact of viral sepsis.